Boston Scientific (BSX) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Boston Scientific (BSX) Q4 'Rock Solid', BofA/Merrill Lynch Says; Likes Risk/Reward Ahead of Ruling
February 4, 2015 12:03 PM ESTBofA/Merrill Lynch analyst Bob Hopkins reiterated a Buy rating and raised his price target on Boston Scientific (NYSE: BSX) to $18.00 (from $16.00) following "rock solid" fourth quarter earnings.
The analyst also notes a ruling from the Judge could come any time on... More
